Results 51 to 60 of about 1,751 (120)

Metformin use in women with polycystic ovary syndrome (PCOS): Opportunities, benefits, and clinical challenges

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue S3, Page 31-47, June 2025.
Abstract Metformin, a synthetic biguanide, is widely used to manage type 2 diabetes, and is commonly prescribed in polycystic ovary syndrome (PCOS) to address insulin resistance and associated metabolic and reproductive disturbances. PCOS is characterised by hormonal imbalances such as hyperandrogenism and anovulation, metabolic abnormalities including
Saeede Saadati   +5 more
wiley   +1 more source

Australasian hidradenitis suppurativa management guidelines

open access: yesAustralasian Journal of Dermatology, Volume 66, Issue 2, Page 75-89, March 2025.
Abstract Hidradenitis Suppurativa is a burdensome inflammatory skin disease with significant quality of life impact. These management guidelines were developed to direct appropriate clinical management in the Australasian context. A systematic review was used for the basis of the consensus guidelines.
John Frew   +12 more
wiley   +1 more source

Notes from the Editor Emeritus: Coincidental Epigenetics or Post-Finasteride Syndrome (PFS)? [PDF]

open access: yesInternational Society of Hair Restoration Surgery, 2016
1. Dow B. Stough, MD (dbs4{at}cablelynx.com) 1. Hot Springs, Arkansas, USA ![][1] The 2016 ISHRS World Congress in Las Vegas featured Dr. Alan Jacobs as guest speaker. Dr. Jacobs is a Neuroendocrinologist in private practice after a stint as Assistant Professor of Neurology ...
openaire   +1 more source

Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?

open access: yesEndocrine, 2018
Sexual dysfunction is a clinical condition due to different causes including the iatrogenic origin. For instance, it is well known that sexual dysfunction may occur in patients treated with antidepressants like selective serotonin reuptake inhibitors (SSRI). A similar side effect has been also reported during treatment with finasteride, an inhibitor of
Giatti S.   +3 more
openaire   +3 more sources

Trazodone and chlorpromazine a proposal treatment for syndrome post-finasteride and syndrome of post-selective serotonin reuptake inhibitors (post-SSRI)

open access: yesWorld Journal of Biology Pharmacy and Health Sciences, 2023
Erectile dysfunction caused by medications are probably caused by the disconnection of synaptic circuits responsible for linking libido to erection. For instance, it is well known that sexual dysfunction may occur in patients treated with antidepressants like selective serotonin reuptake inhibitors, syndrome known as (post-SSRI).
openaire   +1 more source

Post-Finasteride Syndrome And Post-Ssri Sexual Dysfunction: Two Clinical Conditions Apparently Distant, But Very Close

open access: yesFrontiers in Neuroendocrinology
Post-finasteride syndrome and post-SSRI sexual dysfunction, are two poorly explored clinical conditions in which men treated for androgenetic alopecia with finasteride or for depression with SSRI antidepressants show persistent side effects despite drug suspension (e.g., sexual dysfunction, psychological complaints, sleep disorders).
Giatti, Silvia   +3 more
openaire   +2 more sources

MP89-08 POST-FINASTERIDE SYNDROME: REAL OR IMAGINED? [PDF]

open access: yesJournal of Urology, 2016
Michael Butcher   +9 more
openaire   +1 more source

Post-Finasteride Syndrome: An Underestimated Phenomenon

open access: yesUrology and Andrology - Open Journal, 2017
Omer Onur Cakir, Ege Can Serefoglu
openaire   +1 more source

112 Post-Finasteride Syndrome - Outcomes of FDA Database

open access: yesThe Journal of Sexual Medicine, 2016
M. Butcher   +8 more
openaire   +1 more source

004 Post Finasteride Syndrome: is Dutasteride Unfairly Accused?

open access: yesThe Journal of Sexual Medicine, 2016
W. Baas   +9 more
openaire   +1 more source

Home - About - Disclaimer - Privacy